# Phase 6.3.1 — Final Results Integrity Audit Before Research Paper Preparation

**Project:** AI-Based Time-Aware Emergency Blood Donor Recommendation and Dynamic Recruitment System  
**Repository:** `C:\BloodDonor`  
**Audit Scope:** Cross-phase numerical, conceptual, and clinical-policy integrity verification of Phase 6.3 experimental results and longitudinal models.  
**Audit Timestamp:** 2026-10-11  
**Audit Author:** Independent Audit Agent  

---

## 1. Executive Summary & Audit Recommendation

### Final Status: **READY FOR MANUSCRIPT PREPARATION**

All underlying numerical calculations, cluster bootstrap distributions, Holm–Bonferroni multiplicity adjustments, and deterministic scenario generation mechanisms have been independently verified against the raw simulation outputs. 

The audit identified and resolved two critical metric-definition ambiguities in earlier summary narratives:
1. **Resolution of the 4,937 and 5,956 donation figures:** Clarified that these numbers represent the **cumulative total across all 15 timelines** of completed donations that violated the mandatory deferral interval under the unconstrained baseline arms (Arm C and Arm D), translating to **329.1** and **397.1** illegal repeat donations per 180-day timeline.
2. **Resolution of the ~5,000 "prohibited contacts prevented" phrasing:** Clarified that this was an unintentional wording conflation in chat reporting between the ~5,000 cumulative unconstrained repeat donations and the candidate-selection level exclusions. The actual gate metric is **attempted candidate-ranking exclusions**, which averaged **46,724.2** (Arm A) and **47,796.3** (Arm B) per timeline (representing candidate evaluations during wave ranking where a donor was filtered before dispatch consideration), while **actual dispatched notifications** were 4,173.1 (Arm A) and 4,142.1 (Arm B) per timeline.
3. **Statutory vs. Technical Standards Attribution:** Correctly attributed the universal 3-month (90-day) whole-blood minimum interval to the statutory text of the Indian *Drugs and Cosmetics Rules, 1945* (Schedule F, Part XII-B), while attributing the gender-differentiated 4-month (120-day) female interval to the *National Standards for Blood Transfusion Services* issued by the National Blood Transfusion Council (NBTC) / DGHS, MoHFW.

---

## 2. Metric Decoupling & Resolution of Ambiguities

### A. The 6 Distinct Stages in the Simulation State Machine

To prevent any narrative or conceptual conflation in the research manuscript, all experimental quantities are strictly decoupled across six distinct stages:

```
[Candidate Pool] 
       │
       ▼ (1) Deferred Candidate Exclusions: Filtered by temporal gate before ranking
[Ranked & Dispatched] 
       │
       ▼ (2) Dispatched Notifications: Alerts sent via select_batch()
[Responses & Travel] 
       │
       ▼ (3) Arrived Donors: Physically arrived at the emergency site
[Medical Screening] 
       │
       ▼ (4) Clinical Screening Deferrals: Synthetic medical rejection (5% rate)
[Phlebotomy / Collection] 
       │
       ▼ (5) Completed Synthetic Donations: Blood unit collected (if still needed)
[Longitudinal History] 
       │
       ▼ (6) Prohibited Interval Violations: Subsequent donations inside 90d/120d
```

### B. Resolution of the 4,937 / 5,956 Donation Figures

| Metric | Arm A (Fatigue + Cooldown) | Arm B (No Fatigue + Cooldown) | Arm C (Fatigue + No Cooldown) | Arm D (No Fatigue + No Cooldown) |
|---|---:|---:|---:|---:|
| **Total Completed Donations (all 15 TLs)** | 10,434 | 10,413 | 10,687 | 10,681 |
| **Mean Completed Donations per Timeline** | 695.6 | 694.2 | 712.5 | 712.1 |
| **Prohibited Interval Violations (all 15 TLs)** | **0** | **0** | **4,937** | **5,956** |
| **Mean Interval Violations per Timeline** | **0.00** | **0.00** | **329.13** | **397.07** |
| **Min–Max Violations per Timeline** | [0, 0] | [0, 0] | [288, 385] | [351, 463] |
| **Proportion of Donations Violating Deferral** | **0.00%** | **0.00%** | **46.20%** | **55.76%** |

**Audit Conclusion:**
- In the absence of a temporal eligibility gate, **46.2% of all donations in Arm C** and **55.8% of all donations in Arm D** represented clinically premature donations within the prohibited 90-day / 120-day window.
- The reported numbers **4,937** and **5,956** are **15-timeline cumulative sums**. In future manuscript tables, they must be reported alongside their per-timeline means: **329.1 $\pm$ 24.3** (Arm C) and **397.1 $\pm$ 31.8** (Arm D).

### C. Resolution of the Candidate Selection Gate Metric

- **What the Gate Metric Measures:** In [`timeline_metrics.csv`](file:///C:/BloodDonor/reports/phase6_3_donation_eligibility/timeline_metrics.csv), `Attempted_Selections_Prevented` counts every instance where an eligible, blood-compatible donor in the candidate pool was evaluated for an emergency but was excluded from the initial or re-ranked candidate list because `is_temporally_eligible == False`.
- **Numerical Values:**
  - **Arm A:** 46,724.2 candidate evaluations excluded per timeline (across ~272 emergencies, averaging ~171.6 candidate exclusions per emergency incident).
  - **Arm B:** 47,796.3 candidate evaluations excluded per timeline (averaging ~175.5 candidate exclusions per emergency incident).
  - **Arms C & D:** Exactly 0 (no gate applied).
- **Audit Clarification:** Candidate exclusions must **never** be described as "contacts prevented" or "donations prevented." They represent algorithmic exclusions during candidate filtering prior to wave dispatch. Actual notifications dispatched averaged 4,173.1 (Arm A) and 4,142.1 (Arm B) per timeline.

---

## 3. Regulatory Attribution & Clinical Policy Verification

The 90-day and 120-day deferral intervals implemented in Phase 6.3 are grounded in official Indian regulatory frameworks, but require precise legal attribution:

### A. Statutory Text vs. Technical Standards

1. **Statutory Basis: Drugs and Cosmetics Rules, 1945 (as amended)**
   - **Legal Instrument:** Schedule F, Part XII-B, Section I(A) ("Criteria for Selection of Donors").
   - **Issuing Authority:** Central Drugs Standard Control Organization (CDSCO), Ministry of Health and Family Welfare (MoHFW), Government of India.
   - **Statutory Provision:** Whole blood donation interval shall not be less than **3 months (90 days)**. The statutory rule is gender-neutral.
   - **Apheresis Statutory Provision:** 48 hours between plateletpheresis/plasmapheresis procedures (max 2 times/week, 24 times/year); 28-day deferral between whole blood and apheresis procedures.

2. **National Clinical Guidelines: National Standards for Blood Transfusion Services**
   - **Issuing Authority:** National Blood Transfusion Council (NBTC) & Directorate General of Health Services (DGHS), MoHFW, Government of India.
   - **Documents:** *National Standards for Blood Centres* (revised edition) and *Transfusion Medicine Technical Manual*.
   - **Provision:** 
     - **Male whole-blood interval:** **3 months (90 days)**.
     - **Female whole-blood interval:** **4 months (120 days)**.
   - **Clinical Rationale:** The extended 120-day period for female donors accounts for menstrual iron loss and lower baseline ferritin stores, preventing donor iron-deficiency anaemia.

### B. Synthetic Modeling Assumptions (Explicitly Non-Statutory)
The manuscript must clearly identify that:
- The **95% screening pass rate** and **98% phlebotomy completion rate** are synthetic operational parameters designed to prevent deterministic arrival-to-donation mapping, not empirical clinical measurements.
- The **30% female synthetic demographic ratio** was drawn for simulation of heterogeneous policy intervals; the Kaggle dataset does not contain sex or medical history.

---

## 4. Recomputation of Primary Factorial Comparisons

All statistical comparisons were independently verified using the timeline as the independent cluster ($N = 15$ paired timelines, 2,000 bootstrap iterations, Wilcoxon signed-rank test with two-sided continuity correction, and Holm–Bonferroni FWER control on the primary family).

### Comparison 1: Arm A vs. Arm B (Fatigue Effect within Donation Cooldown)

| Endpoint | Family | Arm A Mean | Arm B Mean | Difference (A − B) [95% Bootstrap CI] | Wilcoxon $p$ | Holm $p$ | Statistical Conclusion |
|---|---|---:|---:|---|---:|---:|---|
| **Lookback Repeat Rate** | Primary | 0.3177 | 0.4026 | **-0.0848** $[-0.0906, -0.0797]$ | $6.10 \times 10^{-5}$ | $4.88 \times 10^{-4}$ | **Significant reduction in repeat alerts** |
| **Donors with $\ge 2$ Alerts (%)** | Primary | 43.10% | 40.87% | **+2.23%** $[+1.82\%, +2.66\%]$ | $6.52 \times 10^{-4}$ | $4.56 \times 10^{-3}$ | **Significant pool broadening** |
| **Donors with $\ge 5$ Alerts (%)** | Primary | 17.86% | 17.66% | **+0.21%** $[-0.23\%, +0.68\%]$ | $0.670$ | $1.000$ | Not significant |
| **Max Alerts to Any Donor** | Primary | 17.27 | 19.73 | **-2.47** $[-4.20, -0.73]$ | $0.0233$ | $0.140$ | Unadjusted sig, not post-Holm |
| **Mean Alerts / Donor (Pool)** | Primary | 2.087 | 2.071 | **+0.015** $[-0.006, +0.036]$ | $0.208$ | $0.831$ | Not significant |
| **Alert Fatigue Index (AFI)** | Primary | 5.464 | 5.424 | **+0.040** $[-0.017, +0.093]$ | $0.208$ | $0.831$ | Not significant |
| **Deadline Fulfilment Rate (%)** | Primary | 95.90% | 95.70% | **+0.20%** $[-0.65\%, +0.99\%]$ | $0.638$ | $1.000$ | **No difference (inconclusive / null)** |
| **Mean Fulfilment Latency (min)** | Primary | 32.31 min | 31.71 min | **+0.60 min** $[+0.01, +1.18]$ | $0.0730$ | $0.365$ | Not significant post-Holm |
| **Gini Concentration** | Secondary | 0.658 | 0.685 | **-0.027** $[-0.031, -0.023]$ | $6.10 \times 10^{-5}$ | — | **Significant reduction in inequality** |
| **Mean Alerts / Contacted Donor** | Secondary | 3.874 | 4.068 | **-0.193** $[-0.228, -0.159]$ | $6.10 \times 10^{-5}$ | — | **Significant reduction per contacted donor** |

*Interpretation:* In a donation-constrained longitudinal system, fatigue-aware UDI continues to significantly reduce repeated invitations within the 14-day lookback window by 8.48 percentage points and decreases recruitment inequality across the donor pool without introducing any statistically detectable degradation in deadline fulfillment ($p_{\text{Holm}} = 1.00$).

### Comparison 2: Arm A vs. Arm C (Clinical Cooldown Effect within Fatigue-Aware UDI)

| Endpoint | Arm A (Cooldown) | Arm C (No Cooldown) | Difference (A − C) [95% Bootstrap CI] | Wilcoxon $p$ | Holm $p$ | Operational Finding |
|---|---:|---:|---|---:|---:|---|
| **Deadline Fulfilment Rate (%)** | **95.90%** | **99.53%** | **-3.63%** $[-4.25\%, -3.06\%]$ | $6.10 \times 10^{-5}$ | $4.88 \times 10^{-4}$ | **Simulated clinical penalty: ~3.6%** |
| **Mean Fulfilment Latency (min)** | **32.31 min** | **27.94 min** | **+4.37 min** $[+3.73, +5.02]$ | $6.10 \times 10^{-5}$ | $4.88 \times 10^{-4}$ | **Latency penalty: ~4.4 minutes** |
| **Total Completed Donations** | **695.6** | **712.5** | **-16.9** $[-22.3, -11.2]$ | $9.76 \times 10^{-4}$ | — | **Slight drop in completed units** |
| **Donors with $\ge 2$ Alerts (%)** | **43.10%** | **30.12%** | **+12.98%** $[+12.42\%, +13.57\%]$ | $6.10 \times 10^{-5}$ | $4.88 \times 10^{-4}$ | Pool broader out of necessity |
| **Max Alerts Single Donor** | **17.27** | **24.87** | **-7.60** $[-9.54, -5.87]$ | $6.34 \times 10^{-4}$ | $1.90 \times 10^{-3}$ | Reduced super-donor over-reliance |

*Interpretation:* Enforcing mandatory donation deferral intervals imposes an observable trade-off in simulation: deadline fulfillment drops by **3.63 percentage points** (from 99.53% to 95.90%) and average fulfillment time increases by **4.37 minutes**. When recently donated individuals are made unavailable, the recommendation engine must recruit donors situated further away or with lower response propensities. This highlights the vital importance of modeling donation cooldown in simulation studies.

---

## 5. Cross-Phase Dataset Integrity & Regression Audit

All historical and current phase datasets were verified for row count, checksum stability, and isolation:

| Phase | Core Result Dataset | Expected Records | Verified Records | Status |
|---|---|---:|---:|---|
| **Phase 4** | `reports/phase4_kaggle_comparison/episode_results.csv` | 3,500 | 3,500 | **Unchanged** |
| **Phase 5** | `reports/phase5_ablation_sensitivity/ablation_episode_results.csv` | 3,000 | 3,000 | **Unchanged** |
| **Phase 6.2** | `reports/phase6_2_longitudinal_fatigue/episode_results.csv` | 3,108 | 3,108 | **Unchanged** |
| **Phase 6.3** | `reports/phase6_3_donation_eligibility/episode_results.csv` | 16,340 | 16,340 | **Complete & Verified** |
| **Phase 6.3** | `reports/phase6_3_donation_eligibility/donation_event_history.csv` | 42,215 | 42,215 | **Complete & Verified** |
| **Phase 6.3** | `reports/phase6_3_donation_eligibility/timeline_metrics.csv` | 60 | 60 | **Complete & Verified** |

### Automated Test Suite Status
- **Focused Phase 6.3 Tests (`tests/test_donation_eligibility.py`):** **12 passed, 0 failed** in 0.16s.
- **Full Regression Test Suite:** **254 passed, 0 failed** across all 16 test modules in 5.22s.
- **Single-Episode Equivalence:** Verified that when historical alerts equal zero, Arm A and Arm B produce identical UDI scores and ranks.

---

## 6. Audit Checklist for Research Manuscript Preparation

When drafting the research paper, the writing team must adhere strictly to these scientific reporting rules:

1. **In-Silico Research Framing:** State in the Abstract, Introduction, and Methods that all recruitment episodes, arrival outcomes, and travel times are synthetic simulation outputs. Do not claim clinical validation or proof of donor psychology.
2. **Kaggle Dataset Role:** Explicitly identify that the Kaggle dataset supplied blood groups, cities, and historical donation frequencies, but historical availability was **not** used as an emergency recruitment response model.
3. **Decoupled Metric Reporting:** In all tables comparing cooldown vs. no-cooldown, report:
   - *Attempted candidate exclusions:* ~46,724 / timeline.
   - *Illegal repeat donations prevented:* ~329 (Arm C) to ~397 (Arm D) / timeline (totalling 4,937 and 5,956 across 15 timelines).
   - *Dispatched alerts:* ~4,173 / timeline.
4. **Non-Inferiority Caution:** Do not state that Arm A is "proven non-inferior" to Arm B in deadline fulfillment ($p_{\text{Holm}} = 1.00$). Report it as: "No statistically significant difference in deadline fulfillment was detected between Arm A and Arm B under the simulated assumptions ($\Delta = +0.20\%$, 95% CI: $[-0.65\%, +0.99\%]$)."
5. **Regulatory Citation:** Cite the *Drugs and Cosmetics Rules, 1945* (Schedule F, Part XII-B) for the general 90-day whole-blood interval, and the *NBTC / DGHS National Standards for Blood Centres* for the gender-differentiated 120-day female interval.

---

## 7. Audit Conclusion

The Phase 6.3 results are mathematically robust, internally consistent, fully reproducible, and rigorously verified against the project's source code and datasets.

**Final Status: Approved and Ready for Research Paper Preparation.**
